Related Experiment Video
Updated: Sep 18, 2025

04:54
Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
Published on: March 19, 2021
4.7K
A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral
José Côté1,2,3, Patricia Auger2,3, Gabrielle Chicoine3,4
1Faculty of Nursing, Université de Montréal, Montreal, QC, Canada.
JMIR Formative Research
|June 23, 2025
Summary
This study developed the Joint Effort mobile app to promote lower-risk cannabis use (CU) among young adults using protective behavioral strategies (PBSs). Usability testing showed the app was well-received, visually appealing, and perceived as helpful for behavior change.
Area of Science:
- Digital Health
- Behavioral Science
- Public Health Interventions
Background:
- Canada's legalization of recreational cannabis use (CU) necessitates innovative interventions for lower-risk CU, particularly among young adults (18-25 years).
- Protective behavioral strategies (PBSs) are effective for managing CU and reducing negative consequences, yet few interventions focus on their promotion.
- A mobile app prototype, Joint Effort, was co-designed with young adults to address this gap by promoting PBSs for CU self-management.
Purpose of the Study:
- To describe the development process of the Joint Effort mobile app prototype.
- To evaluate the usability of the Joint Effort app among young adults with recent CU.
- To promote the use of PBSs for CU self-management in young adults.
Main Methods:
- Intervention mapping (IM) and a co-design approach were employed, involving focus groups and a matrix of change objectives.
- Six steps guided development: needs assessment, behavior/determinant selection, theory-based method selection, content validation, preliminary content creation, and app prototyping.
- Usability was assessed via qualitative interviews and the Mobile Application Rating Scale (uMARS) with 20 university students.
Main Results:
- The Joint Effort app was perceived as visually pleasing, easy to use, nonjudgmental, and helpful for initiating behavior change.
- Customization functions were highly appreciated by users.
- The app prototype achieved a high mean uMARS quality score of 4.43/5.0, with strong subscale scores for engagement, functionality, aesthetics, and information quality.
Conclusions:
- The study highlights the value of IM and co-design in developing user-centered mobile health interventions.
- User feedback was crucial in creating an app that is relevant and appealing to young adults.
- The positive usability results have led to the development of an iOS version, with further evaluations planned.
Keywords:
cannabisdevelopmentinterventionmHealthmobile appprototypeself-managementstudentsusabilityyoung adultsMore Related Videos
Related Concept Videos
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Drug Administration and Therapy Phases: Overview
779
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
779

